51. 全身性強皮症 Scleroderma Clinical trials / Disease details
臨床試験数 : 523 / 薬物数 : 608 - (DrugBank : 156) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 215
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01374282 (ClinicalTrials.gov) | January 2010 | 14/6/2011 | Post Marketing Surveillance Study of Cuprimine | Post Marketing Surveillance Study of Cuprimine (MK-0172-001) | Scleroderma | Drug: Cuprimine (penicillamine) | Merck Sharp & Dohme Corp. | NULL | No longer available | N/A | N/A | Both | N/A | NULL |